HTA's Life Sciences group advises companies and their stakeholders on mergers and acquisitions, divestitures, business combinations, capital formation, valuations and fairness opinions. Our clients span the range of early/venture stage businesses to established enterprises with substantial revenue and profitability. Our Life Science investment banking professionals have a significant expertise spanning a wide range of sectors in the life sciences industry including-
- Research & Drug Discovery Tools
- Biotechnology Drug Manufacturing Tools
- Medical Devices
- Applied Markets (e.g., food pathogen testing)
Nephron retained Huron’s investment banking team to arrange a comprehensive refinancing transaction. Huron provided a complete financial advisory solution.